Use of a Promoterless RenillaLuciferase Vector as an Internal Control Plasmid for Transient Co -Transfection Assays of Ras -Mediated Transcription Activation
BioTechniques 26: [24] [25] [26] [27] [28] (January 1999) One problem in studies of gene regulation is selecting an appropriate internal control for transfection efficiency and extract preparation whose expression remains constant during treatments that cause changes in the expression of the gene being studied (2, 6) . This is an especially difficult problem with studies involving activated ras , because most internal control reporters are driven by viral promoters and almost all of these are transactivated by oncogenic rasor other nonnuclear 24BioTechniques Vol. 26, No. 1 (1999) Figure 1 . Ras-mediated transactivation of the human MCSF receptor promoter using either pRL-0 or pRL-CMV as an internal control plasmid. (A) The MCSF receptor promoter in pXP2 and the CMV promoter in pRL-0 are both activated by oncogenic ras , whereas the promoterless vector pRL-0 is not. For transactivation assays, 2 ×10 5 CV1 cells (CCL-70; ATCC, Rockville, MD, USA) were plated in 4 mL of Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) in 60-mm tissue culture plates 18 h before transfection. Cells were transfected by the calcium phosphate method as previously described (4, 14) with: (i) the reporter plasmid: 10 µ g of the promoterless firefly luciferase vector pXP2; 10 µ g of the 159-bp human MCSF receptor promoter (pMCSFR) (-88 to +71 with respect to the major monocytic transcription start site) in pXP2; 0.002 µ g of the CMV promoter in the firefly luciferase vector pXP2; 0.002 µ g of an internal control plasmid using a CMV promoter subcloned in pRL-0 ( Renilla luciferase gene driven by the CMV promoter) (11) or 0.2 or 0.8 µ g of the pRL-0 vector for Renillaluciferase, which lacks eukaryotic promoter and enhancer elements upstream of Renillaluciferase; (ii) 1 µ g of the expression vector: oncogenic pMT3-H-Ras(L61) or the empty expression vector; and (iii) sheared salmon sperm DNA to a total of 15 µ g DNA per plate. The medium was changed after 16 h, and firefly luciferase activities for pXP2 alone and pM-CSFR or pCMV in pXP2 and Renilla luciferase activities for pCMV in pRL-0 and pRL-0 alone were determined 40 h after the initiation of the transfection protocol with the Dual-Luciferase ™Reporter Assay System (Promega). Results were normalized for extract protein content and are given as mean plus standard error of the mean (SEM) of at least 6 independent experiments. (B) Using pRL-0 as an internal control plasmid results in an accurate calibration of the 4-fold transactivation of the MCSF receptor promoter by activated ras , whereas pRL-CMV can not be used as an internal control. Firefly luciferase activities of pMCSFR in pXP2 were normalized to the Renillaluciferase values of either pCMV in pRL-0, 0.2 µ g pRL-0 or 0.8 µ g pRL-0 (data from Panel A).
oncogenes such as receptor and nonreceptor tyrosine kinases, serine/threonine kinases or guanidine triphosphate (GTP)-binding proteins (6) . Thus, some investigators have used "minimal" promoter constructs, such as pTKhGH containing the herpes simplex virus (HSV) thymidine kinase promoter, as internal control plamids for studies of ras -mediated transcription activation (5). However, results of other groups (6) and our own findings (data not shown) suggest that even minimal promoter constructs, such as pBLCAT2 (9) or pTK81-luc (10), which contain the HSV thymidine kinase promoter, are ras -reponsive in the absense of inserted binding sites and, therefore, not useful as internal control plasmids for analysis of ras -mediated transactivation. For these reasons, in transient co-transfection assays investigating transcription activation by ras or other oncogenes, an internal control plasmid is often omitted. Instead, transfections have to be repeated many times, and the values have to be normalized for extract protein content (6) . Overall, the co-transfection assays of ras -mediated transcription activation without an internal control plasmid become very time-consuming, and the results are difficult to interpret. This is especially important when comparing results among different cell lines.
Here, we demonstrate that the pRL-0 vector for Renillaluciferase (Promega, Madison, WI, USA) (7, 8, 11) , which lacks eukaryotic promoter and enhancer elements upstream of the Renillaluciferase gene, works as an internal control plasmid and, most importantly, is not activated by oncogenic ras ( Figure 1A ). While oncogenic ras (L61) (3) activates 4-fold the 159-bp human macrophage colony stimulating factor (MCSF) receptor promoter (-88 to +71 with respect to the major monocytic transcription start site) (15) in the firefly luciferase vector pXP2 (10), the promoterless vector pXP2 is not activated ( Figure 1A) . However, although the promoterless vector pXP2 is not transactivated by ras , it could not easily be used as an internal control plasmid, because the firefly luciferase activity of even 10 µ g pXP2 is only just above background, which would make comparisons in transfection efficacy between plates very difficult. As expected, a potential internal control plasmid using a cytomegalovirus (CMV) promoter subcloned in pRL-0, in which the Renillaluciferase gene is driven by the CMV promoter (7,11), was transactivated 4-fold by oncogenic ras ( Figure  1A ) and therefore cannot be used as an internal control plasmid for studies investigating the effect of activated ras on the MCSF receptor promoter ( Figure  1B) . The promoterless Renilla luciferase vector pRL-0 (11) however is not activated by oncogenic ras , and its Renillaluciferase activity can be measured high above the assay background of 500 relative light units (RLU) because of the approximately 100 × higher sensitivity of the Renillaluciferase assay in comparison to the firefly luciferase assay ( Figure 1A) . Furthermore, the luciferase activity of pRL-0 could be demonstrated to increase linearly with increasing plasmid concentrations. Thus, 0.2 µ g pRL-0 resulted in 40 000 RLU, whereas 160 000 RLU Vol. 26, No. 1 (1999) were measured after transfection of 0.8 µ g pRL-0 ( Figure 1A) .
Because of the high sensitivity of Renilla luciferase in comparison to firefly luciferase, the ratio between control and reporter plasmid can be kept at less than 1:50. Figure 1, A and B , for example, depicts the experiment in which 10 µ g of the MCSF receptor promoter driving firefly luciferase in pXP2 and 0.2 µ g of the internal control plasmid pRL-0 driving Renillaluciferase were used. Moreover, using 0.2 or 0.8 µ g of pRL-0 as an internal control plasmid did not alter the 20-fold transactivation of 0.2 µ g of the collagenase promoter by activated ras (Figure 2) . Thus, even a reporter/control DNA ratio of 1:4 does not lead to promoter competition. Both luciferase activities, the firefly luciferase for the ras responsive promoter being tested and the Renillaluciferase for the internal control plasmid, can be used in the same transfection and assayed sequentially from the same extract in the same tube, minimizing variability. The firefly luciferase reporter is measured first by adding Luciferase Assay Reagent II (Promega) to generate a luminescent signal. After quantifying the firefly luminescence, this reaction is quenched, and the Renillaluciferase reaction is initiated simultaneously by adding Stop and Glo Reagent (Promega) to the same tube.
We have successfully used this assay as an internal control in experiments investigating activation of the transcription factors C/EBP αand PU.1 by oncogenic ras (1, 13) . Furthermore, we have used pRL-0 as an internal control plasmid for transcription activation assays by other activated signaling agonists such as activated MEKK1, in various cell types such as U937, FDCP1/ -FMS, F9, 293T and CV-1 cells and with different transfection methods including calcium phosphate precipitation, L IPOFECT AMINE ™and L IPOFECT -AMINE Plus Reagents (Life Technologies, Gaithersburg, MD, USA) and electroporation (data not shown). In conclusion, these data show that the promoterless vector for Renilla luciferase (pRL-0) is a useful, convenient, relatively inexpensive, very sensitive and rapid internal control plasmid that is not affected by activated ras and is an extremely valuable adjunct to studies investigating transcriptional activation mediated by ras or other nonnuclear oncogenes.
